MetaCap

Trevi Therapeutics Insider Trades

NASDAQ: TRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.02+0.195 (+1.52%)

Market open · Delayed 15 min · as of Oct 9, 11:33 AM ET

Last 12 months

Purchases
0 · $0
Sales
4 · $595.81K
Shares bought / sold
0 / 39.47K
Net activity
Net selling $595,806

Trevi Therapeutics insider activity

Over the last 12 months, Trevi Therapeutics insiders reported 7 transactions on SEC Form 4: 0 open-market purchases and 4 sales. Insiders bought $0 and sold $595,806 worth of stock, for net insider selling of $595,806. The largest seller was Heffernan Michael Thomas, with $595,806 in reported sales.

The most recent filing shows Heffernan Michael Thomas (Director) reporting a transaction in 18,421 shares at $3.04 on Sep 15, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TRVI's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TRVI insider transactions

Trevi Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 15, 2026Heffernan Michael ThomasDirectorSale100$1.59KForm 4
Sep 15, 2026Heffernan Michael ThomasDirectorSale20,952$316.17KForm 4
Sep 15, 2026Heffernan Michael ThomasDirectorOption exercise21,052$70.10KForm 4
Sep 15, 2026Heffernan Michael ThomasDirectorSale100$1.59KForm 4
Sep 15, 2026Heffernan Michael ThomasDirectorSale18,321$276.46KForm 4
Sep 15, 2026Heffernan Michael ThomasDirectorOption exercise18,421$56.00KForm 4
Dec 2, 2025Galletta ChristopherSee RemarksOption exercise4,225$2.16KForm 4
Mar 25, 2025SCIASCIA THOMASChief Scientific OfficerSale2,631$17.36KForm 4
Mar 25, 2025SCIASCIA THOMASChief Scientific OfficerOption exercise2,631$3.76KForm 4
Mar 21, 2025GOOD JENNIFER LPresident & CEOSale5,263$34.62KForm 4
Mar 21, 2025GOOD JENNIFER LPresident & CEOOption exercise5,263$7.53KForm 4
Mar 10, 2025Simon FarrellChief Commercial OfficerSale4,350$31.10KForm 4
Mar 10, 2025Simon FarrellChief Commercial OfficerSale76,963$517.78KForm 4
Mar 10, 2025Simon FarrellChief Commercial OfficerOption exercise31,250$15.97KForm 4
Mar 10, 2025Simon FarrellChief Commercial OfficerOption exercise63,813$249.51KForm 4
Mar 10, 2025Simon FarrellChief Commercial OfficerOption exercise17,500$56.17KForm 4
Jan 8, 2025Delfini LisaChief Financial OfficerOption exercise5,000$2.56KForm 4
Jan 7, 2025Delfini LisaChief Financial OfficerOption exercise1,000$511Form 4
Dec 13, 2024Galletta ChristopherSee RemarksOption exercise15,000$7.67KForm 4
Sep 9, 2024GOOD JENNIFER LPresident & CEOSale1,840$5.59KForm 4
Sep 9, 2024GOOD JENNIFER LPresident & CEOOption exercise1,840$2.63KForm 4
Sep 6, 2024GOOD JENNIFER LPresident & CEOSale4,219$12.78KForm 4
Sep 6, 2024GOOD JENNIFER LPresident & CEOOption exercise4,219$6.03KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related